Broader spectrum
Japanese investors hope Prism's expansion beyond cancer will double valuation
Broader spectrum
Prism Pharma Co. Ltd. plans to use the $15 million it raised in a series C round last week to expand the Japanese company's focus beyond cancer and beef up its valuation.
New
